The clinical profile of NMOSD in Australia and New Zealand
Neuromyelitis optica spectrum disorders (NMOSD) are an inflammation of the central nervous system associated with autoantibodies to aquaporin-4. We have undertaken a clinic-based survey of NMOSD in the Australia and New Zealand populations with the aim of characterising the clinical features and est...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Springer Verlag
2020
|
| _version_ | 1826298424684707840 |
|---|---|
| author | Bukhari, W Clarke, L O'Gorman, C Khalilidehkordi, E Arnett, S Prain, KM Woodhall, M Silvestrini, R Bundell, CS Ramanathan, S Abernethy, D Bhuta, S Blum, S Boggild, M Boundy, K Brew, BJ Brownlee, W Butzkueven, H Caroll, WM Chen, C Coulthard, A Dale, RC Das, C Dear, K Fabis-Pedrini, MJ Fulcher, D Gillis, D Hawke, S Heard, R Henderson, APD Heshmat, S Hodgkinson, S Jimenez-Sanchez, S Kilpatrick, TJ King, J Kneebone, C Kornberg, AJ Lechner-Scott, J Lin, M-W Lynch, C MacDonnell, RAL Mason, DF McCombe, PA Pereira, J Pollard, JD Reddel, SW Shaw, C Spies, J Stankovich, J Sutton, I Vucic, S Walsh, M Wong, RC Yiu, EM Barnett, MH Kermode, AG Marriott, MP Parratt, J Slee, M Taylor, BV Willoughby, E Wilson, RJ Brilot, F Vincent, A Waters, P Broadley, SA |
| author_facet | Bukhari, W Clarke, L O'Gorman, C Khalilidehkordi, E Arnett, S Prain, KM Woodhall, M Silvestrini, R Bundell, CS Ramanathan, S Abernethy, D Bhuta, S Blum, S Boggild, M Boundy, K Brew, BJ Brownlee, W Butzkueven, H Caroll, WM Chen, C Coulthard, A Dale, RC Das, C Dear, K Fabis-Pedrini, MJ Fulcher, D Gillis, D Hawke, S Heard, R Henderson, APD Heshmat, S Hodgkinson, S Jimenez-Sanchez, S Kilpatrick, TJ King, J Kneebone, C Kornberg, AJ Lechner-Scott, J Lin, M-W Lynch, C MacDonnell, RAL Mason, DF McCombe, PA Pereira, J Pollard, JD Reddel, SW Shaw, C Spies, J Stankovich, J Sutton, I Vucic, S Walsh, M Wong, RC Yiu, EM Barnett, MH Kermode, AG Marriott, MP Parratt, J Slee, M Taylor, BV Willoughby, E Wilson, RJ Brilot, F Vincent, A Waters, P Broadley, SA |
| author_sort | Bukhari, W |
| collection | OXFORD |
| description | Neuromyelitis optica spectrum disorders (NMOSD) are an inflammation of the central nervous system associated with autoantibodies to aquaporin-4. We have undertaken a clinic-based survey of NMOSD in the Australia and New Zealand populations with the aim of characterising the clinical features and establishing the value of recently revised diagnostic criteria. Cases of possible NMOSD and age and sex-matched controls with multiple sclerosis (MS) were referred from centres across Australia and New Zealand. Cases were classified as NMOSD if they met the 2015 IPND criteria and remained as suspected NMOSD if they did not. Clinical and paraclinical data were compared across the three groups. NMOSD was confirmed in 75 cases and 89 had suspected NMOSD. There were 101 controls with MS. Age at onset, relapse rates and EDSS scores were significantly higher in NMOSD than in MS. Lesions and symptoms referable to the optic nerve were more common in NMOSD whereas brainstem, cerebellar and cerebral lesions were more common in MS. Longitudinally extensive spinal cord lesions were seen in 48/71 (68%) of cases with NMOSD. Elevations of CSF, white cell count and protein were more common in NMOSD. We have confirmed a clinical pattern of NMOSD that has been seen in several geographical regions. We have demonstrated the clinical utility of the current diagnostic criteria. Distinct patterns of disease are evident in NMOSD and MS, but there remains a large number of patients with NMOSD-like features who do not meet the current diagnostic criteria for NMOSD and remain a diagnostic challenge. |
| first_indexed | 2024-03-07T04:46:37Z |
| format | Journal article |
| id | oxford-uuid:d38603f7-8ef3-4bf8-b18f-9c6c80d0e474 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T04:46:37Z |
| publishDate | 2020 |
| publisher | Springer Verlag |
| record_format | dspace |
| spelling | oxford-uuid:d38603f7-8ef3-4bf8-b18f-9c6c80d0e4742022-03-27T08:12:04ZThe clinical profile of NMOSD in Australia and New ZealandJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d38603f7-8ef3-4bf8-b18f-9c6c80d0e474EnglishSymplectic ElementsSpringer Verlag2020Bukhari, WClarke, LO'Gorman, CKhalilidehkordi, EArnett, SPrain, KMWoodhall, MSilvestrini, RBundell, CSRamanathan, SAbernethy, DBhuta, SBlum, SBoggild, MBoundy, KBrew, BJBrownlee, WButzkueven, HCaroll, WMChen, CCoulthard, ADale, RCDas, CDear, KFabis-Pedrini, MJFulcher, DGillis, DHawke, SHeard, RHenderson, APDHeshmat, SHodgkinson, SJimenez-Sanchez, SKilpatrick, TJKing, JKneebone, CKornberg, AJLechner-Scott, JLin, M-WLynch, CMacDonnell, RALMason, DFMcCombe, PAPereira, JPollard, JDReddel, SWShaw, CSpies, JStankovich, JSutton, IVucic, SWalsh, MWong, RCYiu, EMBarnett, MHKermode, AGMarriott, MPParratt, JSlee, MTaylor, BVWilloughby, EWilson, RJBrilot, FVincent, AWaters, PBroadley, SANeuromyelitis optica spectrum disorders (NMOSD) are an inflammation of the central nervous system associated with autoantibodies to aquaporin-4. We have undertaken a clinic-based survey of NMOSD in the Australia and New Zealand populations with the aim of characterising the clinical features and establishing the value of recently revised diagnostic criteria. Cases of possible NMOSD and age and sex-matched controls with multiple sclerosis (MS) were referred from centres across Australia and New Zealand. Cases were classified as NMOSD if they met the 2015 IPND criteria and remained as suspected NMOSD if they did not. Clinical and paraclinical data were compared across the three groups. NMOSD was confirmed in 75 cases and 89 had suspected NMOSD. There were 101 controls with MS. Age at onset, relapse rates and EDSS scores were significantly higher in NMOSD than in MS. Lesions and symptoms referable to the optic nerve were more common in NMOSD whereas brainstem, cerebellar and cerebral lesions were more common in MS. Longitudinally extensive spinal cord lesions were seen in 48/71 (68%) of cases with NMOSD. Elevations of CSF, white cell count and protein were more common in NMOSD. We have confirmed a clinical pattern of NMOSD that has been seen in several geographical regions. We have demonstrated the clinical utility of the current diagnostic criteria. Distinct patterns of disease are evident in NMOSD and MS, but there remains a large number of patients with NMOSD-like features who do not meet the current diagnostic criteria for NMOSD and remain a diagnostic challenge. |
| spellingShingle | Bukhari, W Clarke, L O'Gorman, C Khalilidehkordi, E Arnett, S Prain, KM Woodhall, M Silvestrini, R Bundell, CS Ramanathan, S Abernethy, D Bhuta, S Blum, S Boggild, M Boundy, K Brew, BJ Brownlee, W Butzkueven, H Caroll, WM Chen, C Coulthard, A Dale, RC Das, C Dear, K Fabis-Pedrini, MJ Fulcher, D Gillis, D Hawke, S Heard, R Henderson, APD Heshmat, S Hodgkinson, S Jimenez-Sanchez, S Kilpatrick, TJ King, J Kneebone, C Kornberg, AJ Lechner-Scott, J Lin, M-W Lynch, C MacDonnell, RAL Mason, DF McCombe, PA Pereira, J Pollard, JD Reddel, SW Shaw, C Spies, J Stankovich, J Sutton, I Vucic, S Walsh, M Wong, RC Yiu, EM Barnett, MH Kermode, AG Marriott, MP Parratt, J Slee, M Taylor, BV Willoughby, E Wilson, RJ Brilot, F Vincent, A Waters, P Broadley, SA The clinical profile of NMOSD in Australia and New Zealand |
| title | The clinical profile of NMOSD in Australia and New Zealand |
| title_full | The clinical profile of NMOSD in Australia and New Zealand |
| title_fullStr | The clinical profile of NMOSD in Australia and New Zealand |
| title_full_unstemmed | The clinical profile of NMOSD in Australia and New Zealand |
| title_short | The clinical profile of NMOSD in Australia and New Zealand |
| title_sort | clinical profile of nmosd in australia and new zealand |
| work_keys_str_mv | AT bukhariw theclinicalprofileofnmosdinaustraliaandnewzealand AT clarkel theclinicalprofileofnmosdinaustraliaandnewzealand AT ogormanc theclinicalprofileofnmosdinaustraliaandnewzealand AT khalilidehkordie theclinicalprofileofnmosdinaustraliaandnewzealand AT arnetts theclinicalprofileofnmosdinaustraliaandnewzealand AT prainkm theclinicalprofileofnmosdinaustraliaandnewzealand AT woodhallm theclinicalprofileofnmosdinaustraliaandnewzealand AT silvestrinir theclinicalprofileofnmosdinaustraliaandnewzealand AT bundellcs theclinicalprofileofnmosdinaustraliaandnewzealand AT ramanathans theclinicalprofileofnmosdinaustraliaandnewzealand AT abernethyd theclinicalprofileofnmosdinaustraliaandnewzealand AT bhutas theclinicalprofileofnmosdinaustraliaandnewzealand AT blums theclinicalprofileofnmosdinaustraliaandnewzealand AT boggildm theclinicalprofileofnmosdinaustraliaandnewzealand AT boundyk theclinicalprofileofnmosdinaustraliaandnewzealand AT brewbj theclinicalprofileofnmosdinaustraliaandnewzealand AT brownleew theclinicalprofileofnmosdinaustraliaandnewzealand AT butzkuevenh theclinicalprofileofnmosdinaustraliaandnewzealand AT carollwm theclinicalprofileofnmosdinaustraliaandnewzealand AT chenc theclinicalprofileofnmosdinaustraliaandnewzealand AT coultharda theclinicalprofileofnmosdinaustraliaandnewzealand AT dalerc theclinicalprofileofnmosdinaustraliaandnewzealand AT dasc theclinicalprofileofnmosdinaustraliaandnewzealand AT deark theclinicalprofileofnmosdinaustraliaandnewzealand AT fabispedrinimj theclinicalprofileofnmosdinaustraliaandnewzealand AT fulcherd theclinicalprofileofnmosdinaustraliaandnewzealand AT gillisd theclinicalprofileofnmosdinaustraliaandnewzealand AT hawkes theclinicalprofileofnmosdinaustraliaandnewzealand AT heardr theclinicalprofileofnmosdinaustraliaandnewzealand AT hendersonapd theclinicalprofileofnmosdinaustraliaandnewzealand AT heshmats theclinicalprofileofnmosdinaustraliaandnewzealand AT hodgkinsons theclinicalprofileofnmosdinaustraliaandnewzealand AT jimenezsanchezs theclinicalprofileofnmosdinaustraliaandnewzealand AT kilpatricktj theclinicalprofileofnmosdinaustraliaandnewzealand AT kingj theclinicalprofileofnmosdinaustraliaandnewzealand AT kneebonec theclinicalprofileofnmosdinaustraliaandnewzealand AT kornbergaj theclinicalprofileofnmosdinaustraliaandnewzealand AT lechnerscottj theclinicalprofileofnmosdinaustraliaandnewzealand AT linmw theclinicalprofileofnmosdinaustraliaandnewzealand AT lynchc theclinicalprofileofnmosdinaustraliaandnewzealand AT macdonnellral theclinicalprofileofnmosdinaustraliaandnewzealand AT masondf theclinicalprofileofnmosdinaustraliaandnewzealand AT mccombepa theclinicalprofileofnmosdinaustraliaandnewzealand AT pereiraj theclinicalprofileofnmosdinaustraliaandnewzealand AT pollardjd theclinicalprofileofnmosdinaustraliaandnewzealand AT reddelsw theclinicalprofileofnmosdinaustraliaandnewzealand AT shawc theclinicalprofileofnmosdinaustraliaandnewzealand AT spiesj theclinicalprofileofnmosdinaustraliaandnewzealand AT stankovichj theclinicalprofileofnmosdinaustraliaandnewzealand AT suttoni theclinicalprofileofnmosdinaustraliaandnewzealand AT vucics theclinicalprofileofnmosdinaustraliaandnewzealand AT walshm theclinicalprofileofnmosdinaustraliaandnewzealand AT wongrc theclinicalprofileofnmosdinaustraliaandnewzealand AT yiuem theclinicalprofileofnmosdinaustraliaandnewzealand AT barnettmh theclinicalprofileofnmosdinaustraliaandnewzealand AT kermodeag theclinicalprofileofnmosdinaustraliaandnewzealand AT marriottmp theclinicalprofileofnmosdinaustraliaandnewzealand AT parrattj theclinicalprofileofnmosdinaustraliaandnewzealand AT sleem theclinicalprofileofnmosdinaustraliaandnewzealand AT taylorbv theclinicalprofileofnmosdinaustraliaandnewzealand AT willoughbye theclinicalprofileofnmosdinaustraliaandnewzealand AT wilsonrj theclinicalprofileofnmosdinaustraliaandnewzealand AT brilotf theclinicalprofileofnmosdinaustraliaandnewzealand AT vincenta theclinicalprofileofnmosdinaustraliaandnewzealand AT watersp theclinicalprofileofnmosdinaustraliaandnewzealand AT broadleysa theclinicalprofileofnmosdinaustraliaandnewzealand AT bukhariw clinicalprofileofnmosdinaustraliaandnewzealand AT clarkel clinicalprofileofnmosdinaustraliaandnewzealand AT ogormanc clinicalprofileofnmosdinaustraliaandnewzealand AT khalilidehkordie clinicalprofileofnmosdinaustraliaandnewzealand AT arnetts clinicalprofileofnmosdinaustraliaandnewzealand AT prainkm clinicalprofileofnmosdinaustraliaandnewzealand AT woodhallm clinicalprofileofnmosdinaustraliaandnewzealand AT silvestrinir clinicalprofileofnmosdinaustraliaandnewzealand AT bundellcs clinicalprofileofnmosdinaustraliaandnewzealand AT ramanathans clinicalprofileofnmosdinaustraliaandnewzealand AT abernethyd clinicalprofileofnmosdinaustraliaandnewzealand AT bhutas clinicalprofileofnmosdinaustraliaandnewzealand AT blums clinicalprofileofnmosdinaustraliaandnewzealand AT boggildm clinicalprofileofnmosdinaustraliaandnewzealand AT boundyk clinicalprofileofnmosdinaustraliaandnewzealand AT brewbj clinicalprofileofnmosdinaustraliaandnewzealand AT brownleew clinicalprofileofnmosdinaustraliaandnewzealand AT butzkuevenh clinicalprofileofnmosdinaustraliaandnewzealand AT carollwm clinicalprofileofnmosdinaustraliaandnewzealand AT chenc clinicalprofileofnmosdinaustraliaandnewzealand AT coultharda clinicalprofileofnmosdinaustraliaandnewzealand AT dalerc clinicalprofileofnmosdinaustraliaandnewzealand AT dasc clinicalprofileofnmosdinaustraliaandnewzealand AT deark clinicalprofileofnmosdinaustraliaandnewzealand AT fabispedrinimj clinicalprofileofnmosdinaustraliaandnewzealand AT fulcherd clinicalprofileofnmosdinaustraliaandnewzealand AT gillisd clinicalprofileofnmosdinaustraliaandnewzealand AT hawkes clinicalprofileofnmosdinaustraliaandnewzealand AT heardr clinicalprofileofnmosdinaustraliaandnewzealand AT hendersonapd clinicalprofileofnmosdinaustraliaandnewzealand AT heshmats clinicalprofileofnmosdinaustraliaandnewzealand AT hodgkinsons clinicalprofileofnmosdinaustraliaandnewzealand AT jimenezsanchezs clinicalprofileofnmosdinaustraliaandnewzealand AT kilpatricktj clinicalprofileofnmosdinaustraliaandnewzealand AT kingj clinicalprofileofnmosdinaustraliaandnewzealand AT kneebonec clinicalprofileofnmosdinaustraliaandnewzealand AT kornbergaj clinicalprofileofnmosdinaustraliaandnewzealand AT lechnerscottj clinicalprofileofnmosdinaustraliaandnewzealand AT linmw clinicalprofileofnmosdinaustraliaandnewzealand AT lynchc clinicalprofileofnmosdinaustraliaandnewzealand AT macdonnellral clinicalprofileofnmosdinaustraliaandnewzealand AT masondf clinicalprofileofnmosdinaustraliaandnewzealand AT mccombepa clinicalprofileofnmosdinaustraliaandnewzealand AT pereiraj clinicalprofileofnmosdinaustraliaandnewzealand AT pollardjd clinicalprofileofnmosdinaustraliaandnewzealand AT reddelsw clinicalprofileofnmosdinaustraliaandnewzealand AT shawc clinicalprofileofnmosdinaustraliaandnewzealand AT spiesj clinicalprofileofnmosdinaustraliaandnewzealand AT stankovichj clinicalprofileofnmosdinaustraliaandnewzealand AT suttoni clinicalprofileofnmosdinaustraliaandnewzealand AT vucics clinicalprofileofnmosdinaustraliaandnewzealand AT walshm clinicalprofileofnmosdinaustraliaandnewzealand AT wongrc clinicalprofileofnmosdinaustraliaandnewzealand AT yiuem clinicalprofileofnmosdinaustraliaandnewzealand AT barnettmh clinicalprofileofnmosdinaustraliaandnewzealand AT kermodeag clinicalprofileofnmosdinaustraliaandnewzealand AT marriottmp clinicalprofileofnmosdinaustraliaandnewzealand AT parrattj clinicalprofileofnmosdinaustraliaandnewzealand AT sleem clinicalprofileofnmosdinaustraliaandnewzealand AT taylorbv clinicalprofileofnmosdinaustraliaandnewzealand AT willoughbye clinicalprofileofnmosdinaustraliaandnewzealand AT wilsonrj clinicalprofileofnmosdinaustraliaandnewzealand AT brilotf clinicalprofileofnmosdinaustraliaandnewzealand AT vincenta clinicalprofileofnmosdinaustraliaandnewzealand AT watersp clinicalprofileofnmosdinaustraliaandnewzealand AT broadleysa clinicalprofileofnmosdinaustraliaandnewzealand |